Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
US10765726B2 · kind B2 · utility
0Cited by
23References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2017 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Dec 6, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates unit dose formulations of antidotes to anticoagulants targeting factor Xa. Disclosed herein are methods of stopping or preventing bleeding in a patient that is currently undergoing anticoagulant therapy with a factor Xa inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.